Építés alatt – nem éles oldal
Belépés
Résztvevőt keresFázis nélkül

Clinical Performance and Safety Assessment of the Use of iCover Balloon Expandable Covered Stent (iVascular) Implanted as Bridging Stent in FEVAR (Fenestrated Endovascular Aortic Repair) for the Treatment of Complex Abdominal Aortic Aneurysms

A legfontosabb adatok

Ki végzi
iVascular S.L.U.
Hol
Barcelona (Spanyolország)A helyszín megnézéseMég 4 másik országban, 23 helyszínen
Azonosító
Állapot
Toboroz
Résztvevők
165 fő, tervezett
Kezdés
2026. febr. 16.
Várható befejezés
2028. szept. 30.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • iCover balloon-expandable covered peripheral stent system as bridging stent
A regiszteradat frissítve
2026. április 14.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for people over 55 with a complex abdominal aortic aneurysm (a bulge in the main belly artery near the kidney arteries). They must be able to have repair with a fenestrated stent graft, using iCover stents to bridge into the branch arteries.

Életkor
Over 55 years
Nem
All sexes
A betegség stádiuma
Juxta-renal, para-renal, suprarenal or thoracoabdominal aneurysm. Size over 5 centimetres (2 in) in women or over 5.5 centimetres (2,2 in) in men, and/or growth over 5 mm in 6 months or 1 centimetre in 1 year. Target arteries must be 5 to 10 mm wide. Life expectancy must be over 12 months.
Korábbi kezelés
People who already have a bridging stent other than iCover in any target artery cannot join.

A részvétel fő kizáró okai

  • Cannot take anti-platelet medicine, or has uncontrolled blood disorders or heparin-induced thrombocytopenia
  • Tear in the aortic wall (aortic dissection), or an infected aneurysm
  • Pregnant or wishing to become pregnant
  • Unstable condition, emergency treatment needed, or heart attack or stroke within 3 months
  • Narrowing over 50% or blockage of the target arteries, or allergy to L605 or PTFE

A regiszter feltételei, szó szerint

Mind a 33 feltétel megnézéseKevesebb

Ki vehet részt

  • Patient suitable for treatment of a juxta, para-renal, suprarenal or thoracoabdominal aneurysm with a fenestrated endoprosthesis in accordance with current indications and guidelines for the management of abdominal aortic aneurysms (aneurysm > 5 centimetres for women and > 5.5 centimetres for men and/or growth > 5 mm in 6 months or 1 centimetre in 1 year)
  • The fenestrated endograft must be designed in a way that positions the fenestrations directly in front of the orifice of the target vessel, ensuring that the distance between the fenestration and the orifice of the target vessel does not exceed 5 mm
  • Anatomy and patient strictly in accordance with the Instructions For Use (IFU) of the fenestrated endograft chosen to be implanted:; Cook Medical: Zenith Fenestrated AAA Endovascular Graft; Terumo Aortic: TREO and Anaconda Fenestrated Stent Grafts; JOTEC (part of Artivion): E-xtra design engineering
  • Additional iCover stent, if necessary, could be placed in the same target artery (2 iCovers stents max as bridging stent for each fenestration)
  • Landing zone in the target vessel of at least 10 mm
  • Target arteries (renal arteries, superior mesenteric artery, celiac trunk) with a diameter between 5 and 10 mm
  • Angulation of the aorta at the level of the target vessels < 45 degrees
  • No early significant branching from the target vessel with a potential risk of coverage and subsequent significant risk of target organ infarctions
  • Age > 55 years
  • Patient having notified his consent to this study and willing to comply with specified follow-up evaluations at the specified times
  • Patient affiliated to or benefiting from a social security system
  • Patient with life expectancy > 12 months

Ki nem vehet részt

  • Patients scheduled for major or life-saving surgery within 30 days of the fenestrated stent procedure
  • Patient is currently participating in another investigational drug or device study that has not completed the entire follow up period that may interfere with the results of this study
  • Myocardial infarction or stroke within 3 months prior to the procedure
  • Patients with uncontrolled haematological disorders or heparin-induced thrombocytopenia
  • Stenosis (>50%) or occlusion of target arteries or distal disease resulting in poor iCover stent outflow
  • Patients allergic to stent materials (L605) and/or PTFE
  • Patients with an unstable angina pectoris or heart insufficiency NYHA 3 or 4
  • Patients contraindicated for anti-platelet therapy
  • Chronic or acute aortic dissection
  • Patients refusing treatment
  • Patients who are pregnant or wish to become pregnant
  • Patients considered hemodynamically unstable or requiring emergency treatment
  • Patients with severe arteriopathy leading to adverse outflow, which may impair bridging stent patency on the targeted artery
  • Thrombus in the aortic sealing zone and target arteries with thickness > to 3 mm
  • Patients requiring a hybrid aortic technique with branches, semibranches or chimneys
  • Patient who has been implanted with any stent type or brand other than iCover as a bridging stent in any target artery
  • Patients with infectious/mycotic aneurysms
  • Angulation between renal artery and aortic wall < 30 degrees
  • Patients with complex iliac accesses out the IFUs of the fenestrated endograft chosen to be implanted (COOK Medical / Terumo Aortic/Jotec-Artivion) with the iCover Bridging stent
  • Patients with ASA classification 5 or higher
  • Patients with physician modified endografts or in situ laser FEVAR

Helyszínek itt: Spanyolország

Még 4 másik országban, 23 helyszínen

  • Hospital Clinic, University of BarcelonaBarcelona, SpanyolországContact: Viçenc Prof. RIAMBAUToborzás még nem indult

A vizsgálatról

Mit akar kideríteni a vizsgálat

fenCo is a European multicentre, prospective study to evaluate the use of the iCover covered stents as bridging stents for reno-visceral target vessel during fEVAR for the treatment of complex abdominal aortic aneurysms.

A vizsgálat csoportja

  • iCover balloon-expandable covered peripheral stent systemA vizsgált kezelés

    Kezelés: iCover balloon-expandable covered peripheral stent system as bridging stent

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2026. április 14.